Clinical Evidence for Rebound Hypercoagulability After Discontinuing Oral Anticoagulants for Venous Thromboembolism

CONTEXT: In vitro studies and anecdotal clinical reports have suggested that clinically significant rebound hypercoagulability may occur after discontinuation of oral anticoagulants (OACs), such as vitamin K antagonists and ximelagatran, for venous thromboembolism (VTE). OBJECTIVE: Assess the extent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Cundiff, David Keith
Formato: Artigo
Lenguaje:Inglês
Publicado: Medscape 2008
Materias:
Departments
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605115/
https://ncbi.nlm.nih.gov/pubmed/19099008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares